- Report
- June 2025
- 272 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 206 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 376 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 303 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 93 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 219 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 273 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 384 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 159 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 188 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 183 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 472 Pages
Global
From €5240EUR$5,850USD£4,467GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more